A phase II trial of apalutamide for intermediate‐risk prostate cancer and molecular correlates
Year: 2024
Type: article
Study design: Clinical Trial
Source: British Journal of Urology
DOI: 10.1111/bju.16414
Authors: Andrew W. Hahn, Ganiraju C. Manyam, Brian F. Chapin, Miao Zhang, Yao Yu, Curtis A. Pettaway, Lisly Chery, Louis L. Pisters, John F. Ward, Justin R. Gregg, John Papadopoulos, Ashish M. Kamat, Marisa Lozano, Anh Hoang, Bradley Broom, Xuemei Wang, Chad D. Huff, Christopher J. Logothetis, Patricia Troncoso, Patrick G. Pilié, John W. Davis
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4399354775